Compare ISTR & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ISTR | EBS |
|---|---|---|
| Founded | 2006 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 372.2M | 434.4M |
| IPO Year | 2014 | 2006 |
| Metric | ISTR | EBS |
|---|---|---|
| Price | $26.57 | $8.01 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $29.00 | $12.00 |
| AVG Volume (30 Days) | 106.6K | ★ 983.7K |
| Earning Date | 04-20-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.65% | N/A |
| EPS Growth | 4.41 | ★ 125.83 |
| EPS | ★ 2.13 | 0.93 |
| Revenue | N/A | ★ $742,900,000.00 |
| Revenue This Year | $66.03 | $29.50 |
| Revenue Next Year | $5.18 | N/A |
| P/E Ratio | $12.47 | ★ $8.61 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $15.39 | $4.02 |
| 52 Week High | $30.49 | $14.06 |
| Indicator | ISTR | EBS |
|---|---|---|
| Relative Strength Index (RSI) | 34.29 | 30.26 |
| Support Level | $26.16 | $7.66 |
| Resistance Level | $27.95 | $9.47 |
| Average True Range (ATR) | 0.77 | 0.50 |
| MACD | -0.17 | -0.02 |
| Stochastic Oscillator | 15.07 | 11.36 |
Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashiers' checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.